Related Experiment Video
Updated: Feb 24, 2026

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Cartilage proteoglycan aggrecan as a predictor of joint damage in juvenile rheumatoid arthritis
Z A el-Sayed1, M T Saleh, A S Al-Wakkad
1Department of Paediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Abstract:
Aggrecan was measured in the sera of 31 children with juvenile rheumatoid arthritis and in the synovial fluid of 10 of them. Patients were evaluated at baseline and 3 months later. Radiographs were repeated also after 1 year. As comparison, 15 apparently healthy children with no disease and 10 children with arthritis due to other collagen vascular diseases were studied. Baseline serum aggrecan was significantly higher in juvenile rheumatoid arthritis patients compared to controls and other patients. On re-evaluation, a significant drop in serum aggrecan from baseline values coincided with a significant drop in clinical and laboratory indices of active inflammation. Serum aggrecan can help to assess the extent of cartilage destruction and is useful as a prognostic tool to predict joint damage in patients with juvenile rheumatoid arthritis.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
The JAK-STAT Signaling Pathway
Growth of Cartilage and Bone Tissue
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Structural Joints: Synovial Joints

